— Know what they know.
Not Investment Advice

APR NASDAQ

Apria, Inc.
1W: +0.1% 1M: +0.4% 3M: +16.7% 1Y: +49.9%
$37.50
Last traded 2022-03-28 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$1.1B +3.3% ▲
4Y CAGR: +1.6%
Gross Profit
$804M +3.0% ▲
4Y CAGR: +2.1%
Operating Income
$101M +41.7% ▲
4Y CAGR: +40.1%
Net Income
$66M +42.3% ▲
4Y CAGR: -9.3%
EPS (Diluted)
$1.86 +42.0% ▲
4Y CAGR: -7.9%
EBITDA
$216M +15.5% ▲
4Y CAGR: +10.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$1.1B$1.1B$1.1B$1.1B$1.1B
YoY Growth+0.0%+3.5%-2.0%+1.8%+3.3%
Cost of Revenue$333M$360M$341M$328M$341M
Gross Profit$741M$751M$748M$780M$804M
Gross Margin69.0%67.6%68.7%70.4%70.2%
R&D Expenses$0$0$0$0$0
SG&A Expenses$672M$699M$721M$709M$707M
Operating Expenses$715M$730M$721M$709M$707M
Operating Income$26M$20M$27M$71M$101M
Operating Margin2.4%1.8%2.5%6.4%8.8%
Interest Expense$1M$1M$5M$6M$12M
Income Before Tax$25M$20M$24M$65M$90M
Tax Expense-$72M$7M$8M$19M$24M
Net Income$97M$13M$16M$46M$66M
Net Margin9.0%1.2%1.4%4.2%5.7%
EPS (Diluted)$2.58$0.35$0.42$1.31$1.86
EBITDA$146M$146M$140M$187M$216M
Shares Outstanding38M38M38M35M35M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms